• DNA Strands

    Most-Read FFB Stories of 2017
    Read our 10 top-read stories of 2017.
    Check them out

  • Young Leaders Group Pic

    Register for the Young Leaders Summit
    The Foundation Fighting Blindness is thrilled to announce details for this year’s National Young Leaders Summit.

    Learn more

  • Bayer Featured Sponsor

    Our Featured Supporter
    Thank you to Bayer for their generous and continued support of the Foundation Fighting Blindness

  • Anson Family

    Racing Against the Clock
    "Every day that goes by, they get closer and closer to permanent blindness."
    Read the full story

The Foundation Fighting Blindness leads the fight against blindness by advancing retinal disease research, education and public awareness.

FFB News

Anson Family Photo

Racing Against the Clock

January 18th, 2018 by FFB Canada

Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and sight. They’ve both had hearing problems from day one, but cochlear implants have helped with that. They also have difficulties with balance, but…

Read More

2018 National Young Leaders Summit: Register Now!

December 28th, 2017 by Dr. Chad Andrews

The Foundation Fighting Blindness is thrilled to announce details for next year’s National Young Leaders Summit. The event will take place in Toronto on the evening of Friday, March 9 and during the day on Saturday, March 10, 2018. We are partnering with the Canadian National Institute for the Blind to hold the Summit at their Community Hub at…

Read More

2017 in Review: The Most-Read FFB Stories of 2017

December 22nd, 2017 by FFB Canada

At the FFB, we love writing about vision research. In 2017, we wrote more than 50 stories to share news about stem cell discoveries, CRISPR gene-editing, promising new drug therapies, and emerging treatments for blinding eye disease. Have you read them all? The best place to start is with our top 10 most-read stories of…

Read More

DNA Strands 2

First gene therapy for a blinding eye disease receives FDA approval

December 19th, 2017 by Dr. Mary Sunderland

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the US that targets a disease caused by mutations in a specific gene. The next steps involve determining the price for Luxturna, which poses…

Read More

Thank you @AMIaudio for inviting us to reflect on Vision Quest 2017 during yesterday's #PulseAMI session. twitter.com/AMIaudio/statu…

About 2 months ago from Fighting Blindness's Twitter via Twitter Web Client

Research and foundation news straight to your inbox.

Sign Up

Enter your email address to receive updates

All fields marked with an asterisk (*) are required

First Name *
Last Name *
Your Email *

Subscribe me to FFB E-News